This inventor holds 1 USPTO granted patent. Top assignee: Elscint Ltd.. Active years: 1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996
Title: Nathan Hermony: Innovator in Nuclear Medicine Imaging
Introduction
Nathan Hermony is a notable inventor based in Haifa, Israel. He has made significant contributions to the field of nuclear medicine through his innovative designs and technologies. His work focuses on enhancing diagnostic imaging systems, which play a crucial role in patient care.
Latest Patents
Nathan Hermony holds a patent for a "Gantry for Nuclear Medicine Imaging Systems." This invention involves a nuclear medicine diagnostic imaging system where the gamma camera rotates around the patient. It is designed to receive electrical power, control signals, and transmit data using cableless coupling means. This advancement allows the system to perform whole body helical scans. Reconstruction of images begins during the first revolution of the camera around the patient and continues through subsequent revolutions, providing evolving images.
Career Highlights
Nathan is associated with Elscint Ltd., a company known for its advancements in medical imaging technology. His work at Elscint Ltd. has been instrumental in developing systems that improve diagnostic capabilities in nuclear medicine.
Collaborations
Throughout his career, Nathan has collaborated with talented individuals such as Dan Inbar and Moshe B Porath. These partnerships have contributed to the success of his projects and innovations.
Conclusion
Nathan Hermony's contributions to nuclear medicine imaging exemplify the impact of innovative thinking in healthcare technology. His patent and work at Elscint Ltd. highlight the importance of advancements in diagnostic imaging systems.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile